Probabilistic methods towards understanding complex human phenotypes using genomic and healthcare data

海量生物数据集的出现挑战了现有的分析框架。大量的基因组分析数据赋予了将特定组织中的突变与基因表达变化联系起来的分子基础。电子病历系统的广泛采用创造了丰富的表型数据，包括诊断代码、实验室测试和问卷调查。这些数据为开发新的机器学习方法提供了有希望的场所，以阐明引起表型多样性和相互依赖性的生物学机制。然而，由于缺乏可扩展的推理方法，现有的研究往往仅限于分析整个数据集的一个小快照，无法解释数据的稀疏、多模态、纵向、不规则采样和非随机缺失的性质。******我们的长期愿景是开发新的机器学习方法，以人类可理解的方式破译基于遗传变异、细胞类型特异性、基因组调控元件、基因和途径功能及其与环境相互作用的各种表型的病因学。为了实现这一愿景，我们提出了四个短期目标。我们将发展：******贝叶斯模型用于解释异质性数据分布的多模态，并通过潜在表型主题关联基因、组织、实验室结果、诊断代码来预测复合生物标志物，***2。生成模型，将相关非随机缺失的实验室结果和患者EHR自我报告问卷的答案与新患者不可获取的组织样本中的基因表达相关联，***3。基于门诊和住院病历纵向和不规则抽样的无监督模型推断不同患者健康状态的潜在轨迹，***4。分层贝叶斯网络，利用从基因组数据推断的序列突变的功能影响，并共同推断驱动遗传变异、因果基因和途径以及表型的定向路径。******我们提出的方法的关键创新之处在于，与现有的特设方法相比，我们同时学习我们提出的模型的所有组件（尽管它们很复杂），因此协调不同的数据集和互补的信息。我们通过利用概率论和深度学习技术的可扩展变分推理算法来实现这一点。******提出的研究将推进贝叶斯学习挖掘大量异构数据，并在医学上有影响力的应用，包括复合生物标志物发现、基于假设的临床建议、预测健康轨迹、个性化风险预测、用于推断因果突变和疾病风险的深度可解释模型。总之，我们通过对大量数据进行有效的贝叶斯整合，向弥合基因组和表型之间的差距迈出了一步，从而提高了我们对从基因突变到广泛表型谱的级联事件的理解。**

The advent of massive biological datasets challenge existing analytic frameworks. Large genomic profiling data confer the molecular basis to link mutations to gene expression changes in specific tissues. The broad adoption of EHR systems creates rich phenotypic data including diagnostic code, lab tests, and questionnaires. These data provide promising venues for developing novel machine learning methods to elucidate the biological mechanisms that give rise to the phenotypic diversities and interdependence. However, due to the lack of scalable inference methods, existing research is often limited to analyzing only a small snapshot of the entire datasets and unable to account for the sparse, multimodal, longitudinal, irregularly sampled, and non-missing-at-random nature of the data. ******Our long-term vision is to develop novel machine learning methods to decipher, in a human-understandable manner, the etiology of diverse phenotypes based on genetic variants, cell-type specificities, genomic regulatory elements, gene and pathway functions, and their interactions with environments. In pursuing this vision, we propose four short-term objectives. We will develop: ******1. Bayesian model to account for the multi-modality of the heterogeneous data distributions and predict composite biomarkers by associating genes, tissues, lab results, diagnosis codes via latent phenotypic topics,***2. generative model to impute correlated non-randomly missing lab results and answers to self-reported questionnaires in patients' EHR and gene expression in inaccessible tissue samples of new patients,***3. unsupervised model to infer latent trajectory of diverse patients' health states based on their longitudinal and irregularly sampled outpatient and inpatient medical records,***4. hierarchical Bayesian network that leverages the functional impacts of sequence mutations inferred from genomic data and jointly infer the directed paths from driver genetic variants, causal genes and pathways, and to phenotypes.******The key innovation of our proposed methods is that, in contrast to the existing ad hoc methods, we learn all components of our proposed models simultaneously (despite their complexity) and therefore harmonize diverse datasets with complementary information. We achieve this by scalable variational inference algorithms that leverage probability theory and deep learning techniques.******The proposed research will advance Bayesian learning for mining massive heterogenous data with impactful applications in medicine including composite biomarker discovery, imputation-based clinical recommendations, forecasting health trajectories, personalized risk predictions, deep interpretable models for inferring causal mutations and disease risks. Together, we present a step towards bridging the gap between the genome and the phenome by efficient Bayesian integrations of massive data, thereby improving our understanding of the cascading events from genetic mutations to a broad phenotypic spectrum. **